payersolutions.cignabigpicture.com Open in urlscan Pro
216.198.212.158  Public Scan

URL: https://payersolutions.cignabigpicture.com/
Submission: On November 10 via automatic, source certstream-suspicious — Scanned from DE

Form analysis 3 forms found in the DOM

POST /search-results/

<form method="post" id="searchForm" class="form-inline float-right" role="search" action="/search-results/">
  <div class="input-group">
    <input type="text" name="Keywords" id="navKeywords" class="form-control" value="" placeholder="Search" aria-label="Search">
    <span class="input-group-btn">
      <button type="submit" class="btn btn-secondary">
        <i class="fa fa-search" aria-hidden="true"></i>
        <span class="sr-only">Search</span>
      </button>
    </span>
  </div>
  <input type="hidden" name="display" value="search">
  <input type="hidden" name="newSearch" value="true">
  <input type="hidden" name="noCache" value="1">
  <input type="hidden" name="csrf_token" value="121A9A3522F8CACB70D0F120EDBE91D2"><input type="hidden" name="csrf_token_expires" value="211110154841162">
</form>

POST /search-results/

<form method="post" id="searchForm" class="float-right" role="search" action="/search-results/">
  <div class="input-group">
    <input type="text" name="Keywords" id="navKeywords" class="form-control" value="" placeholder="Search" aria-label="Search">
    <span class="input-group-btn">
      <button type="submit" class="btn btn-secondary">
        <i class="fa fa-search" aria-hidden="true"></i>
        <span class="sr-only">Search</span>
      </button>
    </span>
  </div>
  <input type="hidden" name="display" value="search">
  <input type="hidden" name="newSearch" value="true">
  <input type="hidden" name="noCache" value="1">
  <input type="hidden" name="csrf_token" value="D92800BFE0CD10143DF407CAC7C20F57"><input type="hidden" name="csrf_token_expires" value="211110154841177">
</form>

<form id="frm6F8E1F62-FC99-E696-4CC32EB32B27CA69" class="mura-form" novalidate="novalidate" enctype="multipart/form-data">
  <div class="error-container-6F8E1F62-FC99-E696-4CC32EB32B27CA69"></div>
  <div class="field-container-6F8E1F62-FC99-E696-4CC32EB32B27CA69">
    <div class="mura-control-group form-group req" id="field-firstname-container">
      <label for="field-firstname" data-for="firstname">First Name <ins>Required</ins></label>
      <input type="text" name="firstname" id="field-firstname" class="form-control" value="">
    </div>
    <div class="mura-control-group form-group req" id="field-lastname-container">
      <label for="field-lastname" data-for="lastname">Last Name <ins>Required</ins></label>
      <input type="text" name="lastname" id="field-lastname" class="form-control" value="">
    </div>
    <div class="mura-control-group form-group req" id="field-company-container">
      <label for="field-company" data-for="company">Company <ins>Required</ins></label>
      <input type="text" name="company" id="field-company" class="form-control" value="">
    </div>
    <div class="mura-control-group form-group req" id="field-email-container">
      <label for="field-email" data-for="email">Email Address <ins>Required</ins></label>
      <input type="text" name="email" id="field-email" class="form-control" value="">
    </div>
    <div class="mura-control-group form-group req" id="field-jobfunction-container">
      <div class="mura-radio-group">
        <label class="mura-group-label" for="jobfunction"> Job Function <ins>Required</ins>
        </label>
        <div class="form-check">
          <input type="radio" name="jobfunction" class="form-check-input" id="field-8ec1c1d1-7abe-4049-96d2-bed561f71b6d" value="Employer">
          <label for="field-8ec1c1d1-7abe-4049-96d2-bed561f71b6d" class="form-check-label">Employer</label>
        </div>
        <div class="form-check">
          <input type="radio" name="jobfunction" class="form-check-input" id="field-60b9cb75-5731-4ccd-b150-6ab66b53a169" value="Producer">
          <label for="field-60b9cb75-5731-4ccd-b150-6ab66b53a169" class="form-check-label">Producer</label>
        </div>
      </div>
    </div>
    <div style="display:none" class="cffm_applied"></div>
    <input id="fp6FCF78B9-0B37-A5DA-D1E3B1B09612D925" type="hidden" name="formfield1234567891" class="cffp_mm" value="">
    <input id="fp6FCF78BA-C2F6-B093-851AC1D54370A251" type="hidden" name="formfield1234567892" class="cffp_kp" value="">
    <input id="fp6FCF78BB-FCE5-EC9F-58EE24E11B109AC6" type="hidden" name="formfield1234567893" value="39951316,19865052">
    <label style="display:none">Leave this field empty <input id="fp6FCF78BC-FFEA-D2DE-73ABC14D72E03EA5" type="text" name="formfield1234567894" value=""></label>
  </div>
  <div class="paging-container-6F8E1F62-FC99-E696-4CC32EB32B27CA69"><button class="mura-form-submit form-submit btn btn-primary" type="button" data-page="1">Submit</button> </div>
  <input type="hidden" name="formid" value="6F8E1F62-FC99-E696-4CC32EB32B27CA69">
</form>

Text Content

Search
Search


Close
 * What's Trending
 * News & Insights
   Total Cost of Care Approach Holistic Customer Experience
 * Clinical Updates & Pipeline
   Clinical Updates Drug Pipeline Review
 * The Studio

 * Cigna Broker Portal Login


THE DOSE

INTEGRATED PHARMACY INSIGHTS
AND UPDATES FROM CIGNA




PRECISION SUPPORT FOR 15 DIVERSE CONDITIONS – INCLUDING HIV

Around-the-clock support for specialty conditions is not just nice to have, it’s
necessary. The Accredo Therapeutic Resource Center® (TRC) model is always ready
to offer essential support and guidance for those taking life-changing and
life-saving specialty medications to treat complex conditions. And these TRCs
are available for all Cigna customers who receive specialty medications
through Accredo®, Cigna's specialty pharmacy.

Read more


CIGNA PHARMACY JANUARY 2022 CLINICAL UPDATE

At Cigna, plan affordability is always top of mind. Our latest comprehensive
drug review and actions span across medical and pharmacy drug utilization
to help promote appropriate and cost-effective medication use and expanded
choice.

Read more


PHARMACY MEDICATION RECALL READINESS

When medication recalls, withdrawals and safety alerts happen, Cigna Pharmacy
quickly communicates the latest details. We assess the situation, identify any
impacts and determine necessary next steps. Please review this summary of
notable recent recalls.

Read more


COVID-19 VACCINES SPREAD HOPE AS CIGNA HELPS SPREAD THE WORD

Cigna welcomes and encourages the use of available COVID-19 vaccines authorized
by the U.S. Food and Drug Administration (FDA).

Read more


CIGNA PHARMACISTS HELP ENRICH COLLABORATIVE CARE

Cigna Collaborative CareTM (CCC) is one of Cigna’s overall efforts to encourage
value-driven care. For customers that have integrated medical and pharmacy
benefits with Cigna, our clinical pharmacists play the important role of helping
to improve medication adherence and close evidence-based clinical gaps in care.

Read more


MY MEDICATIONS EMPOWERS CUSTOMERS TO MANAGE MEDS WITH EASE

My Medications is a brand new digital tool available for Cigna customers as of
June 2021. Like a virtual medicine cabinet, it opens the door to track and
manage prescription medications conveniently from anywhere. To access My
Medications, customers simply log in to the myCigna® App or website. From there,
they see a current, full view of their prescriptions – available 24/7.

Read more


CIGNA’S MEDICAL SPECIALTY DRUG MANAGEMENT UPDATE

Medical specialty drugs must be administered in a health care setting and are,
thus, covered under the medical benefit. They comprise about half of all
specialty drugs and make up about 23% of total health care spend.1 As part of
our efforts to help manage these costs, effective July 2021, medical specialty
drug program enhancements will occur.

Read more


CIGNA CONTINUES EFFORTS TO LOWER PRESCRIPTION DRUG COSTS BY PROMOTING
BIOSIMILARS

Innovative Shared Savings Program offers eligible Remicade patients $500
one-time incentive for switching to a clinically equivalent biosimilar.

Read more


EVICORE HELPS BRING TREATMENT CLARITY FOR CUSTOMERS FACING CANCER

In 2021, there will be an estimated 1.9 million new cancer cases diagnosed and
608,570 cancer deaths in the United States.1 While new drugs and therapies bring
fresh hope for those with a cancer diagnosis, they also mean a growing sea of
decisions for customers and health care providers to make. Contributing an extra
dose of expertise to assist this process, eviCore helps confirm the best course
of care.

Read more


UNLOCKING THE POTENTIAL OF BIOSIMILARS

Biologic medicines have transformed treatment for many complex and debilitating
conditions, including cancer, multiple sclerosis, and rheumatoid arthritis, but
the health care system cannot continue to sustain the current rate of specialty
drug spend increases. The good news is that biosimilar products offer savings
opportunities to help mitigate the growing and costly biologic specialty drug
market through competition. 

Read more


CIGNA’S DRUG PIPELINE REVIEW

The U.S. drug pipeline is not just an indication of future life-changing and
saving medications, but it’s also an indication of future health care costs.
Cigna always has a pulse on the latest updates to the drug pipeline, as well as
impending patent expirations. Take a look at our drug pipeline review that
includes traditional and specialty pipeline news.

Read more


FIGHTING THE SUBSTANCE ABUSE TREND WITH CIGNA INTEGRATED BENEFITS

The trauma of life events can trigger dangerous choices. Unfortunately, the
added anxieties of pandemic life have led many to up their intake of alcohol or
other unhealthy substances. At Cigna, the advantages of having health care
benefits integrated under one roof is in having a connected, clear picture of an
individual’s health from which to identify potential risk factors and intervene,
when possible. This is key for those with already fragile health, for whom the
choice to engage in substance abuse could be of grave consequence.

Read more


PREVENTIVE MEDICATION PROGRAM OFFERS EMPLOYERS MORE CHOICE AND MEMBERS GREATER
ADHERENCE OPPORTUNITIES

Non-adherence to prescribed treatment is thought to cause at least 100,000
preventable deaths and $100 billion in preventable medical costs per year. Cost
is a common concern. Cigna's Preventive Medication Program can help. Clients who
elect this program can choose to waive customer’s deductible and/or cost share
on program medications, eliminating cost as a medication adherence issue.

Read more


STRONG UTILIZATION MANAGEMENT CHECKPOINTS HELP IMPROVE OUTCOMES AND SAVE

At Cigna, we maintain a detailed path of utilization management (UM) checkpoints
that we apply to all medication claims, especially those for specialty
medications, to help customers receive safe, cost-effective treatments.

Read more


GUIDING TO THE IDEAL SITES OF CARE FOR MEDICAL SPECIALTY PHARMACY

Choosing where to receive treatment with a medical specialty drug will have
impacts on multiple levels. These complex drugs are often injected or infused by
a health care professional. The setting where this takes place should offer high
quality service. It should be within reasonable proximity to the customer’s
home. Final costs also shouldn’t be double or even triple those of rival care
settings. That’s where Cigna's Specialty Care Options program focuses its
efforts.

Read more


CIGNA’S PATIENT ASSURANCE PROGRAMSM EXPANDS, MAKING MORE MEDS MORE AFFORDABLE

As of April 1, 2021, our Patient Assurance Program (PAP) will expand coverage
for eligible customers to include additional branded diabetes medications based
on the formulary elected by the employer.

Read more


PROVEN SUCCESS TO HELP LOWER A1C LEVELS FOR PATIENTS WITH DIABETES

As part of our SafeGuardRx® for Cigna program, Cigna provides one-on-one drug
adherence counseling and support that’s proven to help lower A1C levels. When
engaging with a Cigna coach through this program, 63% of those with an A1C level
of 8 or above were able to lower their A1C levels to a goal of less than 8.

Read more


CIGNA HELPS BROADEN ACCESS TO LIFE-CHANGING GENE THERAPIES

When it comes to treating diseases, gene therapy may deliver truly
transformational results. Gene therapy also holds promise to treat a wide range
of diseases, such as cancer, cystic fibrosis, heart disease and hemophilia –
conditions caused by a dysfunctional or mutated gene. Gene therapies target the
underlying cause of a disease at the cellular level by either replacing a faulty
gene with a healthy copy of the gene or by adding a new or modified gene. This
is often accomplished with a single treatment. Our Cigna Gene Therapy Program
contracts with providers who have access to gene therapy products. We strive to
manage quality and control costs for the emerging realm of gene therapy.

Read more


CIGNA PROVIDER CONTRACTING AND STEERAGE HELPS MANAGE SPECIALTY SPEND

For those who need specialty medications to treat a complex, chronic condition,
the right care facility can help keep costs down and health outcomes positive.
Cigna works to control costs in a variety of ways including provider
contracting.

Read more

2:42


MANAGING SPECIALTY MEDICATION COSTS WITH CIGNA INTEGRATED BENEFITS

At Cigna, we know managing specialty pharmacy costs goes well beyond just the
unit cost of a drug. From site of care, specialists, hospitalizations,
comorbidities, and mental health conditions, supporting our members and clients
holistically is critical to help ensure the best health outcomes and lowest
total medical costs.

Watch Now








CIGNA PHARMACY MANAGEMENT®

As a Pharmacy Benefits Manager within a global health service company, we
uniquely deliver personalized solutions that support the whole person. Through
integrated capabilities, we address every aspect of our customers’ wellness,
including physical and emotional health. Our goal is to deliver greater value to
you and your employees, helping them improve their well-being while you control
your costs.


FOLLOW US

 * 
 * 
 * 
 * 
 * 

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Product availability may vary by location and plan type and is subject to
change. All group health insurance policies and health benefit plans contain
exclusions and limitations. For costs and details of coverage, review your plan
documents or contact a Cigna representative.

All Cigna products and service are provided exclusively by or through operating
subsidiaries of Cigna Corporation, including Cigna Health and Life Insurance
Company, (CHLIC), Evernorth Care Solutions, Inc., Evernorth Behavioral Health,
Inc., Cigna Health Management, Inc., Evernorth, Accredo Health Group, Inc.,
Express Scripts, Inc., ESI Mail Pharmacy Service, Inc., Express Scripts
Pharmacy, Inc., Tel-Drug, Inc., Tel-Drug of Pennsylvania, L.L.C., Lynnfield
Drug, Inc., and HMO or service company subsidiaries of Cigna Health Corporation.
Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1
et al. (CHLIC). The Cigna name, logo, and other Cigna marks are trademarks of
Cigna Intellectual Property, Inc. "Express Scripts" is a trademark of Express
Scripts Strategic Development, Inc. This newsletter is not intended for
residents of New Mexico.

© 2021 Cigna. All rights reserved

 Subscribe to The Dose and stay up-to-date on the latest industry news, insights
and updates from Cigna Pharmacy.

First Name Required
Last Name Required
Company Required
Email Address Required
Job Function Required
Employer
Producer

Leave this field empty
Submit